Low Risk Lifestyle Behaviors and Risk of Cardiovascular Disease: A Systematic Review and Meta-analys
Authors: Suleman Ahmad
Keywords: Risk, Lifestyle, Behaviours, Cardiovascular, Disease, Systematic, Review, Meta- analysis,Prospective, Cohort .
Abstract
Holy Qur’an recommends physical activity, eating healthy, and avoiding addictive substances. All these recommendations are part of what is known as low-risk lifestyle behaviors in modern medicine and have been associated with reduced risk of cardiovascular mortality in individual studies. We conducted a systematic review and meta- analysis to quantify the association of all-cause mortality with adherence to multiple low-risk lifestyle behaviors. METHODS: Searches in Medline, EMBASE, and Cochrane (through June 14, 2017) were conducted. Prospective cohort studies reporting association between multiple-lifestyle behaviors (at least three low-risk lifestyle behaviors including healthy diet) with risk of all-cause mortality were included. Low-risk lifestyle behaviors were defined as healthy body weight (minimum BMI <25kg/m2), healthy diet (minimum daily intake of vegetables), regular physical activity (minimum ≥20min/day, 3 times/week), smoking cessation (minimum >12months), and moderate alcohol consumption (up to 30g/day). Two independent reviewers extracted the data and assessed study quality (Newcastle-Ottawa Scale). Risk estimates of extreme comparisons were pooled using inverse variance random effects models. Inter-study heterogeneity was assessed (Cochran Q statistic) and quantified (I2 statistic). The overall certainty of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. RESULTS: 21 cohort comparisons (696,476 participants, 69,679 all-cause mortality cases) were eligible. Adherence to all possible low-risk lifestyle behaviors compared to none was associated with a 55% lower incidence of cardiovascular disease (risk ratio, 0.45 [95% confidence interval, 0.37 to 0.55]). The overall certainty of the evidence was graded as “high” using the GRADE system owing to upgrades for a large magnitude of effect and significant dose-response gradient in the absence of any downgrades.
Timeline
Received
Oct 10, 2018
Revised
Oct 25, 2018
15 days later
Accepted
Nov 15, 2018
21 days later
Published
Nov 3, 2024
2180 days later